March 8, 2026 11:50 pm
Published by Diana Dugas
Professional Background: Dr. Manja Kubeil studied chemistry at the Technische Universität Dresden (Germany) and undertook her doctoral studies on metal-based radiopharmaceutical agents at Institute of Radiopharmaceutical Cancer Research, HZDR. In 2014 she received her doctoral degree from Technische Universität Dresden with highest distinction and was awarded with a Marie Skłodowska-Curie International Outgoing Fellowship. From 2015 until 2017 she was working in the group of Prof. Leone Spiccia and Dr. Bim Graham at Monash University, School of Chemistry and Monash Institute... Read More
June 20, 2025 4:25 am
Published by Diana Dugas
Professional Background: Dr Nigel Lengkeek is the Principal Radiochemist in the Department of Nuclear at Liverpool Hospital and the Manager of the Liverpool Hospital Cyclotron Facility, ensuring the reliable daily manufacturing of routine clinical radiopharmaceuticals and supporting theranostic clinical trials and research. Nigel completed his PhD at UWA, moving to ANSTO in 2010. During his 13 years at ANSTO he worked on a broad range of projects covering radiopharmaceutical discovery and development, radioisotope generators, radioactive medical devices and radiopharmaceutical translation,... Read More
May 22, 2025 3:40 am
Published by Diana Dugas
Professional Background: Yanling is a technical leader with strong expertise in biopharmecautical product development and manufacturing. She was initially trained as an applied chemist in China and later obtained her Master and PhD degrees in Physical Biochemistry in the UK. Prior to moving to Australia in 2009, she was a Senior Scientist in Bioprocess Development at MedImmune Cambridge UK (now AstraZeneca) leading antibody characterisation and formulation development. In the last 18 years, Yanling has led R&D teams in the biotech sector across UK,... Read More
October 8, 2024 10:17 pm
Published by Diana Dugas
Professional Background: Since joining ANSTO in 2000 as a postdoctoral research fellow, Ivan has been a key player in the field of radiochemistry. His expertise lies in the development of diagnostic radiopharmaceuticals using F-18, Tc-99m, and I-123 radioisotopes. In 2003, he was appointed as a Radiochemist and, in 2010, he took on the role of Head of Radiochemistry. In this capacity, Ivan has successfully managed a team of radioisotope and radiopharmaceutical scientists, overseeing the delivery of technologies and products to... Read More
August 5, 2024 5:54 am
Published by ntechmedia
Professional Background: Solid Targetry manager at Austin Hospital from 2012 to 2021. Cyclotron engineer at the Austin Hospital from 2001 to 2012. Bachelor in Medical Biophysics and Instrumentation. Research Interests: Co-founded iPHASE technologies in 2003 and CEO. LinkedIn Company Profile iPhase Company Website
August 5, 2024 5:50 am
Published by Diana Dugas
Professional Background: Sam Graf is Head of Innovation and Partnerships at Cyclotek. Following the completion of his Master of Science at the University of Melbourne, Sam worked at the Peter MacCallum Cancer Centre as a Clinical Trial Coordinator. In 2022, Sam joined the team at Cyclotek to manage Cyclotek’s R&D projects and industry-academia collaborations. Research Interests: Sam completed his Master of Science under Professor Paul Donnelly at the University of Melbourne. There, his research focused on the synthesis and characterisation... Read More
August 5, 2024 5:33 am
Published by ntechmedia
Professional Background: Since completing a PhD in UK at Cambridge University, and starting my career with Cambridge Antibody Technology (Medimmune, UK) to my current role at Telix Pharmaceuticals, I have been fortunate to have worked in a number of technical or research roles with biotechnology industry leaders in precision medicine. I have also worked in senior development roles at a number of successful smaller companies including Medicines Development Limited, Hatchtech and Starpharma Limited; performing activities related to GMP clinical manufacture,... Read More
August 5, 2024 5:20 am
Published by ntechmedia
Professional Background: Loan completed her PhD at the University of Sydney in 2013 and then undertook postdoctoral training at Westmead Institute for Medical Research (2013-2017) and the University of Sydney (2017-2019). In November 2019, Loan joined ANSTO as a Biologist in the Biosciences Platform and in 2020, she was appointed Manager of Biology & Preclinical Imaging. In her current role, she leads and manages biologists, imaging scientists and infrastructure, to undertake biological research in radiopharmaceutical translation, radiation biology and radiotracer... Read More
August 5, 2024 5:03 am
Published by ntechmedia
Professional Background: Greg Santamaria is the Co-Founder, Director and CEO of Cyclotek. Over multiple decades Greg has gained extensive experience in business development and operations, asset management and finance structuring. Greg holds several board and consultancy positions within private companies in the fields of healthcare, manufacturing, wholesale and finance. Since 2016 Greg has been CEO of the Cyclotek group, which compounds and distributes diagnostic and therapeutic radiopharmaceuticals across Australia and New Zealand. Research Interests: Throughout his time at Cyclotek, Greg... Read More
August 5, 2024 4:59 am
Published by ntechmedia
Professional Background: Kristof Zarschler completed his university studies in Biology at theTechnische Universität Dresden (TUD), Germany in 2005 and received his PhDwith distinction from the Department of Nanobiotechnology at the Universityof Natural Resources and Life Science Vienna (BOKU), Austria in 2009. Beforejoining the Institute of Radiopharmaceutical Cancer Research (IRCR) of theHelmholtz-Zentrum Dresden-Rossendorf (HZDR) in 2011, Kristof was apostdoctoral research associate at the Institute for Genetics of the TUD(2010-2011). Kristof is currently research associate at the Department ofMedicinal Radiochemistry of the... Read More
